Order results by:
Issue | Title | |
Vol 12, No 6 (2020) | Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes | Abstract similar documents |
D. V. Ivashchenko, A. S. Osipov, E. V. Nazarova, M. A. Ovchinnikova, N. I. Buromskaya, V. V. Smirnov, P. V. Shimanov, R. V. Deitch, T. A. Fainshtein, E. N. Shagovenko, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
"... CYP3A4/5 and CYP2D6 metabolize most antipsychotics. The activity of these isoenzymes in children ..." | ||
Vol 10, No 4 (2018) | Pharmacogenetics of schizophrenia in real clinical practice: a clinical case | Abstract similar documents |
R. F. Nasyrova, N. A. Schnaider, K. O. Mironov, G. A. Shipulin, O. P. Dribnokhodova, E. A. Golosov, M. Yu. Tolmachev, B. V. Andreev, A. A. Kurylev, L. Sh. Akhmetova, О. V. Limankin, N. G. Neznanov | ||
"... and financial expenditure on treatment. The basic drugs in these patients are antipsychotics that are highly ..." | ||
Vol 12, No 5 (2020) | The polymorphic variants DRD2 rs1800497 and ABCB1 3435C>T are associated with antipsychotic safety parameters in adolescents with an acute psychotic episode: the results of a pilot study | Abstract PDF (Eng) similar documents |
D. V. Ivashchenko, S. Z. Khoang, M. Kh. Tazagulova, B. V. Makhmudova, N. I. Buromskaya, P. V. Shimanov, R. V. Deitch, I. V. Dorina, M. I. Nastovich, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
"... taking antipsychotics. Pharmacogenetic testing allows one to more accurately choose the initial dose ..." | ||
Vol 13, No 4 (2021) | Treatment of antipsychotic-induced parkinsonism in schizophrenic patients | Abstract similar documents |
E. E. Vaiman, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
"... Antipsychotic-induced parkinsonism (AIP) is one of the prognostically unfavorable complications ..." | ||
Vol 17, No 1 (2025) | The use of antipsychotics in the real-world clinical practice in Russia (based on the results of the EPIDEMICUS program) | Abstract similar documents |
V. E. Medvedev | ||
"... The optimization of antipsychotic therapy is an urgent issue not only in psychiatry ..." | ||
Vol 12, No 6 (2020) | The interaction of folate cycle enzyme genes and the risk of extrapyramidal side effects of antipsychotics | Abstract PDF (Eng) similar documents |
T. V. Zhilyaeva, E. V. Akimova, A. S. Blagonravova, G. E. Mazo | ||
"... of the key folate cycle enzymes in developing the extrapyramidal side effects of antipsychotics has not yet ..." | ||
Vol 13, No 3 (2021) | Off-label antipsychotics prescription to adolescents with acute psychotic episodes does not cause adverse drug reactions | Abstract PDF (Eng) similar documents |
D. V. Ivashchenko, N. I. Buromskaya, A. D. Malakhova, N. A. Tsarkova, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
"... Antipsychotics are often used to treat children and adolescents. Because of their age ..." | ||
Vol 5, No 1 (2013) | Bipolar affective disorders: the specific features of the course and maintenance pharmacotherapy | Abstract similar documents |
Nina Arkadyevna Tyuvina, V N Smirnova | ||
Vol 11, No 4 (2019) | Antipsychotic-induced tardive dyskinesia as a serious adverse effect in the psychopharmacotherapy of schizophrenia | Abstract similar documents |
E. E. Vaiman, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
"... -aged people. Movement disorders, or extrapyramidal syndrome, are potentially reversible antipsychotic ..." | ||
Vol 14, No 2 (2022) | Association between redox imbalance, pterin metabolism markers, and early extrapyramidal side effects of antipsychotics in schizophrenia: pilot study | Abstract similar documents |
T. V. Zhilyaeva, D. S. Shvachkina, A. S. Piatoikina, E. S. Zhukova, O. V. Kostina, T. G. Shcherbatyuk, G. E. Mazo | ||
"... Antipsychotics (AP) administration in schizophrenia patients is associated with several side ..." | ||
Vol 14, No 1 (2022) | Drug-induced liver injury with cholestasis in the neurologist and psychiatric practice | Abstract PDF (Eng) similar documents |
O. D. Ostroumova, E. V. Shikh, N. V. Shikh, T. M. Ostroumova, Y. A. Isaakyan | ||
"... : paroxetine, sertraline, fluoxetine, citalopram, escitalopram), antidepressants), antipsychotics ..." | ||
Vol 14, No 2 (2022) | Treatment of mental disorders of generative cycle in women | Abstract similar documents |
V. E. Medvedev | ||
"... , anxiolytics, antipsychotics with an emphasis on good tolerance, a minimum of adverse events, compatibility ..." | ||
Vol 11, No 1 (2019) | Antidepressant therapy in patients with cardiovascular diseases | Abstract similar documents |
V. E. Medvedev, E. A. Korovyakova, V. I. Frolova, E. V. Gushanskaya | ||
"... with their negative effect on the hepatic cytochrome CYP450 isoenzymes involved in the metabolism of various drugs ..." | ||
Vol 13, No 6 (2021) | Drug-induced parkinsonism | Abstract PDF (Eng) similar documents |
T. M. Ostroumova, O. D. Ostroumova, A. S. Soloveva | ||
"... commonly associated with antipsychotic drugs, monoamine reuptake inhibitors, and calcium channel blockers ..." | ||
Vol 12, No 5 (2020) | Drug-induced dystonia | Abstract PDF (Eng) similar documents |
T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova, V. A. Parfenov | ||
"... from one antipsychotic medication to another, especially to its injectable dosage form. Tardive DID ..." | ||
Vol 4, No 4 (2012) | 60 th anniversary of the design of antipsychotics (on their classification) | Abstract similar documents |
Dmitry Sergeyevich Danilov | ||
"... The paper describes the most important periods in the history of the design of antipsychotics ..." | ||
Vol 12, No 1 (2020) | Drug-induced tardive dyskinesia | Abstract similar documents |
T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova, V. A. Parfenov | ||
"... taking metoclopramide, antipsychotics, antidepressants, calcium channel blockers, and other drugs ..." | ||
Vol 12, No 2 (2020) | Pharmacogenetics of the safety of phenazepam in alcohol withdrawal syndrome: haplotype and combinatorial analyses of polymorphic variants in the pharmacokinetic factor genes | Abstract similar documents |
D. V. Ivashchenko, O. V. Tereshchenko, I. I. Temirbulatov, K. A. Akmalova, E. A. Grishina, M. S. Zastrozhin, L. M. Savchenko, E. A. Bryun, D. A. Sychev | ||
"... by cytochrome P450 3A (CYP3A) isozymes. Since their substrates have an affinity for P-glycoprotein ..." | ||
Vol 14, No 3 (2022) | Neuropsychiatric disorders correction in Alzheimer's disease | Abstract similar documents |
N. N. Koberskaya | ||
"... . Antipsychotics are often associated with serious side effects and increased mortality in patients with dementia ..." | ||
Vol 4, No 1 (2012) | Sleep disorders in mental diseases and their correction | Abstract similar documents |
Nina Arkadyevna Tyuvina, E P Shchukina, E A Izotova | ||
"... of sanval both alone and in combination with other psychotropic drugs (antidepressants and antipsychotics ..." | ||
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders | Neurocognitive deficit in patients with schizophrenia | Abstract similar documents |
A. B. Shmukler, I. Ya. Gurovich, Yu. S. Zaitseva | ||
"... antipsychotics on the time course of changes in neurocognitive impairments in patients with the first psychotic ..." | ||
Vol 15, No 6 (2023) | Non-interventional epidemiological program for investigating the real-life practice of using quetiapine (Seroquel®) in patients with schizophrenia and bipolar affective disorder (EPIDEMICUS) | Abstract similar documents |
V. E. Medvedev, I. G. Kuznetsova | ||
"... as a highly effective and well-tolerated antipsychotic with a broad spectrum of activity that goes beyond ..." | ||
Vol 13, No 2 (2021) | Drug-induced hypersomnia | Abstract PDF (Eng) similar documents |
T. M. Ostroumova, O. D. Ostroumova, A. V. Filippova, T. F. Guseva | ||
"... . Most often, the development of DIH is associated with the use of levodopa-carbidopa, antipsychotics ..." | ||
Vol 17, No 2 (2025) | Drug-induced dyskinesia when taking Fluvoxamine | Abstract similar documents |
A. A. Katok, D. M. Khasanova, I. A. Khasanov | ||
"... of antidepressants and antipsychotics prescribed and an increasing awareness of possible side effects. Fluvoxamine ..." | ||
Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmacogenetic approaches | Abstract similar documents |
P. N. Vlasov, N. V. Orekhova, M. V. Antonyuk, N. V. Filatova, N. A. Schnaider, D. V. Dmitrenko, S. N. Zobova, I. E. Poverennova, A. V. Yakunina, V. A. Kalinin, S. K. Zyryanov, I. F. Tishchenkova | ||
"... polymorphisms (SNPs) CYP2C9*3 (27.3%) versus those who had the common (wild-type) allele variant CYP2C9*1 ..." | ||
Vol 13, No 6 (2021) | Treatment of noncognitive neuropsychiatric disorders in Alzheimer's disease | Abstract similar documents |
A. B. Lokshina, D. A. Grishina | ||
"... for antipsychotic administration in this disease, NСNPDs treatment in AD, which includes nonpharmacological ..." | ||
Vol 14, No 1 (2022) | Comparative evaluation of psychopharmacotherapy of atypical depression in bipolar and recurrent affective disorder, psychogenic depression | Abstract PDF (Eng) similar documents |
M. S. Verbitskaya, N. A. Tyuvina, Yu. G. Tyulpin, G. L. Krenkel | ||
"... , or a combination of AD and antipsychotic (A), AD and A, MS and A, as well as a combination of AD, A and MS ..." | ||
Vol 12, No 3 (2020) | Drug-induced cognitive impairment | Abstract similar documents |
O. D. Ostroumova, M. I. Kulikova, T. M. Ostroumova, M. S. Chernyaeva, A. I. Kochetkov, V. A. Parfenov | ||
"... Many classes of medications, such as antipsychotics, anticonvulsants, anticholinergics, and other ..." | ||
Vol 12, No 4 (2020) | Chemotranscriptome analysis indicates the neurotrophic and neuromodulator effects of a citicoline molecule | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov, I. A. Shchukin | ||
"... , including antiepileptic drugs (n=20), dopaminergic agents (n=19), antipsychotics (n=38), anxiolytics (n=21 ..." | ||
Vol 6, No 3 (2014) | Alcohol abuse and related disorders treatment of alcohol dependence | Abstract similar documents |
Yu. P. Sivolap | ||
"... in using antipsychotics to suppress a craving for alcohol (as well as other psychoactive substances ..." | ||
Vol 12, No 2 (2020) | Investigation of the efficiency of various antidepressant replacement regimens in the development of SSRI-induced apathy syndrome | Abstract similar documents |
V. E. Medvedev, R. A. Kardashyan, V. I. Frolova, A. M. Burno, S. V. Nekrasova, V. I. Salyntsev | ||
"... thymoleptic effect, including when combined with the antipsychotic sulpiride (50 mg/day). ..." | ||
Vol 10, No 1 (2018) | Cognitive impairment in anxiety disorders | Abstract similar documents |
B. A. Volel, D. S. Petelin, R. V. Akhapkin, A. A. Malyutina | ||
"... frequently used drugs (antidepressants, atypical antipsychotics, anticonvulsants, tranquilizers) does ..." | ||
Vol 13, No 5 (2021) | Alcohol-Induced Psychotic Disorder and Depressive Disorder: a Dual Diagnosis Case Series | Abstract PDF (Eng) similar documents |
A. Elbelushi, Z. Muravec, H. Masood, B. Masood | ||
"... (SAPAS) and Modified Sainsbury Tool. Antidepressants and antipsychotics were chosen based on drug ..." | ||
Vol 13, No 3 (2021) | Depression treatment in women and men with bipolar affective disorder: a comparative study | Abstract similar documents |
N. A. Tyuvina, A. E. Stolyarova, V. V. Balabanova, K. M. Bunkova, E. N. Efremova | ||
"... , antipsychotics combinations were used to treat depression. We performed a comparative analysis of treatment ..." | ||
Vol 4, No 1 (2012) | Experience in using sulpiride in non-psychotic endogenous depressive-hypochondriacal disorders | Abstract similar documents |
Nina Arkadyevna Tyuvina, V. V. Balabanova, E M Goncharova | ||
"... in depressive-hypochondriacal syndrome and to its antipsychotic and activating activities in SPS. ..." | ||
Vol 8, No 3 (2016) | Chemoreactome analysis of ethylmethylhydroxypyridine succinate | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, L. E. Fedotova, A. N. Gromov | ||
"... and the enzymes monoamine oxidase and cytochrome CYP1A1) distinguish EMHPS from the molecules of comparison ..." | ||
1 - 36 of 36 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)